These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28363284)

  • 1. Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma.
    Li Z; Yao Q; Zhao S; Wang Z; Li Y
    Artif Intell Med; 2017 Feb; 76():1-6. PubMed ID: 28363284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of autophagy-related genes in esophageal adenocarcinoma.
    Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
    BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
    Xu T; Yuan Y; He C; Yang K
    Med Sci Monit; 2021 Jan; 27():e927850. PubMed ID: 33510126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
    Lan T; Liu W; Lu Y; Luo H
    Medicine (Baltimore); 2021 Apr; 100(14):e25305. PubMed ID: 33832101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes.
    Duan L; Cao L; Zhang R; Niu L; Yang W; Feng W; Zhou W; Chen J; Wang X; Li Y; Zhang Y; Liu J; Zhao Q; Fan D; Hong L
    Bioengineered; 2021 Dec; 12(1):3434-3454. PubMed ID: 34252349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
    Kim SM; Park YY; Park ES; Cho JY; Izzo JG; Zhang D; Kim SB; Lee JH; Bhutani MS; Swisher SG; Wu X; Coombes KR; Maru D; Wang KK; Buttar NS; Ajani JA; Lee JS
    PLoS One; 2010 Nov; 5(11):e15074. PubMed ID: 21152079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
    Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
    J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
    Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
    Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
    Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
    Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
    Kang H; Wang N; Wang X; Zhang Y; Lin S; Mao G; Liu D; Dang C; Zhou Z
    Aging (Albany NY); 2020 Nov; 12(24):25828-25844. PubMed ID: 33234735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.
    Lynam-Lennon N; Bibby BA; Mongan AM; Marignol L; Paxton CN; Geiersbach K; Bronner MP; O'Sullivan J; Reynolds J; Maher SG
    Mol Med; 2016 May; 22():388-97. PubMed ID: 27254108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
    Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.
    Guo X; Tang Y; Zhu W
    BMC Genomics; 2018 Oct; 19(1):769. PubMed ID: 30355311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma.
    Zaidi AH; Pratama MY; Omstead AN; Gorbonova A; Mansoor R; Melton-Kreft R; Jobe BA; Wagner PL; Kelly RJ; Goel A
    Br J Cancer; 2022 Nov; 127(11):2016-2024. PubMed ID: 36097175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
    Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
    Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
    Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
    Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus.
    Eluri S; Brugge WR; Daglilar ES; Jackson SA; Styn MA; Callenberg KM; Welch DC; Barr TM; Duits LC; Bergman JJ; Shaheen NJ
    Am J Gastroenterol; 2015 Jun; 110(6):828-34. PubMed ID: 26010308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.